Earnings ·
Teleflex raises full-year adjusted EPS guidance to $7.50-$7.75 after Q3 results
TFXTeleflex Inc
Teleflex reported third-quarter revenue of $567.8 million and adjusted diluted earnings per share of $2.63, beating prior year levels. The company raised its 2026 full-year adjusted EPS guidance range to $7.50-$7.75 from previous estimates, while maintaining pro forma adjusted constant currency revenue growth guidance of 3.5% to 4.5%. Teleflex also announced the completion of its OEM business divestiture for $1.5 billion and repurchased $350 million in stock since July. The company continues to advance the pending sale of its Acute Care and Interventional Urology businesses, targeting a year-end close subject to regulatory approval. Teleflex is a global provider of medical technologies and devices.